Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 26.06 CNY 1.16% Market Closed
Market Cap: 10.9B CNY

Liaoning Chengda Biotechnology Co Ltd
Investor Relations

Liaoning Chengda Biotechnology Co., Ltd. is engaged in the research, development, manufacture and sale of vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,663 full-time employees. The company went IPO on 2021-10-28. The firm's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The firm's products include two brands: Chengda Suda and Chengda Libao.

Show more
Loading
688739
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yu Mao
GM & Director
No Bio Available
Mr. Jianwei Cui
Deputy GM, CFO & Secretary
No Bio Available
Mr. Weiqiang Sun
Deputy GM & Chief Scientist
No Bio Available
Mr. Junwei Yang
Deputy GM & Director
No Bio Available
Mr. Deming Yuan
Deputy General Manager
No Bio Available

Contacts

Address
LIAONING
Shenyang
No. 1, Xinfang Street, Hunnan New District
Contacts
+862483782632
www.cdbio.cn